DNA in cancer cells leads to DNA damage under the action of therapeutic factors, such as radiotherapy and alkylating drugs, while PARP, as an intracellular DNA repair enzyme, can repair mutant damage in DNA, thus making the tumor resistant to these treatments [7]. The gene discussed is LIG4; the disease is cancer.